Cargando…
Successful treatment with tocilizumab for refractory anemia and slowly progressive renal glomerulosclerosis in multicentric Castleman disease: A case report
RATIONALE: Multicentric Castleman disease (MCD) is a rare lymphoproliferative disorder accompanied by systemic symptoms characterized by polyclonal hypergammaglobulinemia and chronic inflammation due to overexpression of interleukin-6. Histological heterogeneity of renal involvement in MCD has been...
Autores principales: | Sugawara, Eri, Sato, Taiki, Amasaki, Yoshiharu, Katsumata, Kazuaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878775/ https://www.ncbi.nlm.nih.gov/pubmed/35212301 http://dx.doi.org/10.1097/MD.0000000000028941 |
Ejemplares similares
-
Effectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis: Two case reports
por: Asano, Tomoyuki, et al.
Publicado: (2020) -
Treatment-resistant idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, renal dysfunction, and organomegaly managed with Janus kinase inhibitors: A case report
por: Kakutani, Takuya, et al.
Publicado: (2022) -
Refractory Uveitis in Patient with Castleman Disease Successfully Treated with Tocilizumab
por: Oshitari, Toshiyuki, et al.
Publicado: (2012) -
Hypocomplementemia during tocilizumab treatment: Long-term follow-up results
por: Bieber, Amir, et al.
Publicado: (2022) -
Focal segmental glomerulosclerosis lagged behind the onset of rheumatoid arthritis by 7 years: A case report and literature review
por: Liu, Yang, et al.
Publicado: (2017)